CA125 response to bevacizumab in recurrent ovarian cancer. Background: Management of advanced ovarian carcinoma (AOC) involves surgery in order to achieve surgical cytoreduction followed by platinum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results